Reprogramming tumor-associated macrophages by a dually targeted mExo system as a potent monotherapy for cancer.

[1]  Liang Gong,et al.  An off-the-shelf small extracellular vesicle nanomedicine for tumor targeting therapy. , 2023, Journal of controlled release : official journal of the Controlled Release Society.

[2]  A. Kishimura,et al.  Engineered macrophages acting as a trigger to induce inflammation only in tumor tissues based on arginase 1-responsive TNF-α accelerated release. , 2023, Journal of controlled release : official journal of the Controlled Release Society.

[3]  Xinmei Wang,et al.  Exosomes—Nature’s Lipid Nanoparticles, a Rising Star in Drug Delivery and Diagnostics , 2022, ACS nano.

[4]  J. Wolchok,et al.  Clinical implications of T cell exhaustion for cancer immunotherapy , 2022, Nature Reviews Clinical Oncology.

[5]  Yuan Yin,et al.  Hyaluronic Acid-Coated Bovine Milk Exosomes for Achieving Tumor-Specific Intracellular Delivery of miRNA-204 , 2022, Cells.

[6]  J. Zempleni,et al.  Milk exosomes in nutrition and drug delivery. , 2022, American journal of physiology. Cell physiology.

[7]  F. jia,et al.  Tumor‐derived exosomes induce immunosuppressive macrophages to foster intrahepatic cholangiocarcinoma progression , 2022, Hepatology.

[8]  Peiwen J. Ma,et al.  Landscape and perspectives of macrophage -targeted cancer therapy in clinical trials , 2022, Molecular therapy oncolytics.

[9]  Yuan Yin,et al.  Colorectal Cancer‐Derived Small Extracellular Vesicles Promote Tumor Immune Evasion by Upregulating PD‐L1 Expression in Tumor‐Associated Macrophages , 2022, Advanced science.

[10]  R. Weiskirchen,et al.  Milk exosomal microRNAs: friend of foe?—a narrative review , 2022, ExRNA.

[11]  Jinhong Chen,et al.  Molecular mechanism of CD163+ tumor-associated macrophage (TAM)-derived exosome-induced cisplatin resistance in ovarian cancer ascites , 2022, Annals of translational medicine.

[12]  Yuan Yin,et al.  Nanobody-Engineered Natural Killer Cell Conjugates for Solid Tumor Adoptive Immunotherapy. , 2021, Small.

[13]  Zihai Li,et al.  Combination strategies to maximize the benefits of cancer immunotherapy , 2021, Journal of Hematology & Oncology.

[14]  Yubin Huang,et al.  Engineering Endogenous Tumor‐Associated Macrophage‐Targeted Biomimetic Nano‐RBC to Reprogram Tumor Immunosuppressive Microenvironment for Enhanced Chemo‐Immunotherapy , 2021, Advanced materials.

[15]  J. Joyce,et al.  Therapeutic Targeting of the Tumor Microenvironment. , 2021, Cancer discovery.

[16]  Xiang Gao,et al.  PD-L1 induces macrophage polarization toward the M2 phenotype via Erk/Akt/mTOR. , 2021, Experimental cell research.

[17]  M. Mandal,et al.  Nano formulated Resveratrol inhibits metastasis and angiogenesis by reducing inflammatory cytokines in oral cancer cells by targeting tumor associated macrophages. , 2021, The Journal of nutritional biochemistry.

[18]  Jianguo Wang,et al.  Targeting tumor-associated macrophages to synergize tumor immunotherapy , 2021, Signal Transduction and Targeted Therapy.

[19]  Y. Kaneda,et al.  Hemagglutinating virus of Japan‐envelope containing programmed cell death‐ligand 1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma , 2020, Cancer science.

[20]  M. Qi,et al.  Targeted ferritin nanoparticle encapsulating CpG oligodeoxynucleotides induces tumor-associated macrophage M2 phenotype polarization into M1 phenotype and inhibits tumor growth. , 2020, Nanoscale.

[21]  J. Kzhyshkowska,et al.  Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers , 2020, Frontiers in Oncology.

[22]  Yuan Yin,et al.  Exosome‐mediated delivery of miR‐204‐5p inhibits tumor growth and chemoresistance , 2020, Cancer medicine.

[23]  Yan-fang Yang,et al.  Targeted delivery of chlorogenic acid by mannosylated liposomes to effectively promote the polarization of TAMs for the treatment of glioblastoma , 2020, Bioactive materials.

[24]  Zhimeng Wu,et al.  Hyaluronan decoration of milk exosomes directs tumor-specific delivery of doxorubicin. , 2020, Carbohydrate research.

[25]  W. Di,et al.  Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy , 2020, Theranostics.

[26]  C. Pichon,et al.  Comparative binding and uptake of liposomes decorated with mannose oligosaccharides by cells expressing the mannose receptor or DC-SIGN. , 2019, Carbohydrate research.

[27]  Shuo Wang,et al.  Multifunctional biomimetic nanoparticles loading baicalin for polarizing tumor-associated macrophages. , 2019, Nanoscale.

[28]  R. Herbst,et al.  Immune Cell PD-L1 Colocalizes with Macrophages and Is Associated with Outcome in PD-1 Pathway Blockade Therapy , 2019, Clinical Cancer Research.

[29]  Zhongwu Guo,et al.  Site-specific C-terminal dinitrophenylation to reconstitute the antibody Fc functions for nanobodies† †Electronic supplementary information (ESI) available: Enzyme and nanobody expression, experimental methods, supporting figures, and synthetic details. See DOI: 10.1039/c9sc03840j , 2019, Chemical science.

[30]  Fujun Li,et al.  Colon Cancer Cell Secretes EGF to Promote M2 Polarization of TAM Through EGFR/PI3K/AKT/mTOR Pathway , 2019, Technology in cancer research & treatment.

[31]  R. Cubas,et al.  Anti-PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment. , 2019, Cancer research.

[32]  J. Varner,et al.  Targeting Tumor-Associated Macrophages in Cancer. , 2019, Trends in immunology.

[33]  A. Ross,et al.  RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer Immunotherapy , 2019, Scientific Reports.

[34]  B. Brüne,et al.  Selective targeting of tumor associated macrophages in different tumor models , 2018, PloS one.

[35]  Xinrui Zhao,et al.  Immobilization of Staphylococcus aureus Sortase A on Chitosan Particles and Its Applications in Peptide-to-Peptide Ligation and Peptide Cyclization , 2018, Molecules.

[36]  Yuan Yin,et al.  The Immune-microenvironment Confers Chemoresistance of Colorectal Cancer through Macrophage-Derived IL6 , 2017, Clinical Cancer Research.

[37]  Song Shen,et al.  Spatial Targeting of Tumor-Associated Macrophages and Tumor Cells with a pH-Sensitive Cluster Nanocarrier for Cancer Chemoimmunotherapy. , 2017, Nano letters.

[38]  Lori A. Coburn,et al.  EGFR-mediated Macrophage Activation Promotes Colitis-associated Tumorigenesis , 2017, Oncogene.

[39]  Heather H Gustafson,et al.  Serum Stability and Affinity Optimization of an M2 Macrophage-Targeting Peptide (M2pep) , 2016, Theranostics.

[40]  S. Pun,et al.  Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[41]  Harvey F Lodish,et al.  Engineered red blood cells as carriers for systemic delivery of a wide array of functional probes , 2014, Proceedings of the National Academy of Sciences.

[42]  Jinghang Zhang,et al.  CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis , 2011, Nature.

[43]  Xuan Zheng,et al.  Enhancement of folate receptor alpha expression in tumor cells through the glucocorticoid receptor: a promising means to improved tumor detection and targeting. , 2005, Cancer research.